Technology areas: Chemistry & Materials • Medical Devices & Mechanical Engineering
5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
SIO2 Medical Products Inc. currently has 5 pending office actions located within the Medical Devices & Mechanical Engineering technology area. These actions are spread across 5 distinct examiners and 4 distinct art units, showing a high degree of diversification in the personnel and units reviewing the company's applications. This suggests that the company's medical device innovations are technically varied or are being routed to multiple specialized niches within the USPTO.
The busiest examiner for the portfolio is HALL, DEANNA K, who is assigned 1 pending office action. With a busiest examiner pending count of 1 and a total of 5 pending office actions, the workload is evenly distributed among the 5 distinct examiners. This distribution means that the company's prosecution success is not dependent on any single individual, providing a broad base of feedback across the Medical Devices & Mechanical Engineering sector.
For practitioners, the requirement to interface with 4 distinct art units for 5 pending office actions necessitates a versatile and well-coordinated prosecution strategy. Each of the 5 distinct examiners will bring their own perspective to the review process. This structure provides a level of protection against localized delays, as the company's overall progress is distributed across multiple examination tracks and individuals.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (80%) |
| Multi-statute (no §101) | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HALL, DEANNA K | 1 | 75.7% | +15.3% |
| ARBLE, JESSICA R | 1 | 66.6% | +25.0% |
| ROMANOWSKI, MICHAEL C | 1 | 53.0% | +62.8% |
| CHATRATHI, ARJUNA P | 1 | 62.0% | +22.3% |
| PEO, KARA M | 1 | 42.5% | +37.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18018868 | METHOD AND PACKAGE FOR REDUCING THE DEGRADATION OF A DRUG AND/OR EXCIPIENT, E.G. POLYSORBATE STABILIZER, IN A PHARMACEUTICAL PRODUCT | PEO, KARA M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18552708 | ATOMIC LAYER DEPOSITION COATED PHARMACEUTICAL PACKAGING AND IMPROVED SYRINGES AND VIALS, E.G. FOR LYOPHILIZED/COLD-CHAIN DRUGS/VACCINES | CHATRATHI, ARJUNA P | 44d overdue |
| 18560187 | Drug Primary Package Having Integrated RFID Tag | ARBLE, JESSICA R | 36d overdue |
| 18843492 | IMPROVED SYRINGE AND GASKET SYSTEMS | HALL, DEANNA K | — |
| 18498734 | STERILIZABLE PHARMACEUTICAL PACKAGE FOR OPHTHALMIC FORMULATIONS | ROMANOWSKI, MICHAEL C | — |
| 18018868 | METHOD AND PACKAGE FOR REDUCING THE DEGRADATION OF A DRUG AND/OR EXCIPIENT, E.G. POLYSORBATE STABILIZER, IN A PHARMACEUTICAL PRODUCT | PEO, KARA M | — |
| Art Unit | Apps |
|---|---|
| 3781 | 2 |
| 3783 | 1 |
| 1782 | 1 |
| 1777 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18843492 | IMPROVED SYRINGE AND GASKET SYSTEMS | HALL, DEANNA K | 3783 | §103 | Non-Final OA | — | Pending | Sep 03, 2024 |
| 18560187 | Drug Primary Package Having Integrated RFID Tag | ARBLE, JESSICA R | 3781 | §103 | Final Rejection | 36d overdue | Pending | Nov 10, 2023 |
| 18498734 | STERILIZABLE PHARMACEUTICAL PACKAGE FOR OPHTHALMIC FORMULATIONS | ROMANOWSKI, MICHAEL C | 1782 | §103 | Final Rejection | — | Pending | Oct 31, 2023 |
| 18552708 | ATOMIC LAYER DEPOSITION COATED PHARMACEUTICAL PACKAGING AND IMPROVED SYRINGES AND VIALS, E.G. FOR LYOPHILIZED/COLD-CHAIN DRUGS/VACCINES | CHATRATHI, ARJUNA P | 3781 | §103 | Final Rejection | 44d overdue | Pending | Sep 27, 2023 |
| 18018868 | METHOD AND PACKAGE FOR REDUCING THE DEGRADATION OF A DRUG AND/OR EXCIPIENT, E.G. POLYSORBATE STABILIZER, IN A PHARMACEUTICAL PRODUCT | PEO, KARA M | 1777 | §102§112 | Non-Final OA | — | Pending | Jan 30, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSIO2 Medical Products Inc. has 5 pending office actions as of October 2026, spread across 4 art units and 5 examiners.
Deanna K Hall has the most, with 1 of SIO2 Medical Products Inc.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
